The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Ferring; ipsen; Janssen; Sanofi
Research Funding - AstraZeneca (Inst)
Travel, Accommodations, Expenses - ipsen; Janssen; Sanofi
PROPEL: A randomized, phase III trial evaluating the efficacy and safety of olaparib combined with abiraterone as first-line therapy in patients with metastatic castration-resistant prostate cancer (mCRPC).
 
Noel W. Clarke
No Relationships to Disclose
 
Andrew J. Armstrong
Honoraria - Dendreon; Janssen Oncology; Sanofi
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; Bayer; Dendreon; Janssen Biotech; Medivation; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Dendreon; Sanofi
Research Funding - Active Biotech (Inst); Astellas Pharma (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Gilead Sciences (Inst); Janssen Oncology (Inst); Medivation (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc; Bayer; Dendreon; Janssen Biotech
 
Antoine Thiery-Vuillemin
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Johnson & Johnson; Novartis; Pfizer; Roche; Sanofi
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Johnson & Johnson; Novartis; Pfizer; Roche; Sanofi
Research Funding - Pfizer
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Johnson & Johnson; Pfizer; Roche
 
Mototsugu Oya
Honoraria - Astellas Pharma; AstraZeneca; Janssen; Sanofi; Takeda
Research Funding - Astellas Pharma
 
Dingwei Ye
No Relationships to Disclose
 
Joaquin Mateo
Consulting or Advisory Role - AstraZeneca
Speakers' Bureau - Astellas Pharma; AstraZeneca; Sanofi
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Sanofi
 
Carsten Dietrich Goessl
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Jinyu Kang
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Sherry Liu
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Fred Saad
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Janssen Oncology (Inst); Sanofi (Inst)